Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area


Por: Gimenez-Perez, G, Vlacho, B, Navas, E, Mata-Cases, M, Real, J, Cos, X, Franch-Nadal, J, Mauricio, D

Publicada: 1 sep 2022 Ahead of Print: 1 ago 2022
Resumen:
Aim: To assess the prevalence of autoimmune diseases (AID) in patients with type 1 diabetes (T1D) and to evaluate whether the rate of diabetes-related complications differs depending on the presence of AID. Methods: Cross-sectional analysis of 13,570 T1D patients aged >= 18 years registered in the SIDIAP database. The association between AID and diabetes-related complications was assessed by multivariable logistic regression models. Results: The prevalence of AID was 18.3% with thyroid AID being the most common. Patients with T1D and AID were more often female and their current age, age of diabetes onset and diabetes duration were higher. Patients with only thyroid AID experienced a lower risk of peripheral artery disease (odds ratio [OR] = 0.51, 95%; confidence interval [CI] 0.31 to 0.81) and kidney disease (OR = 0.68, 95%; 95% CI 0.54 to 0.85), whereas patients with other AID had an increased risk of ischemic heart disease (OR = 1.48, 95%; 95% CI 1.04 to 2.06). Conclusions: The burden of diabetes-related complications in patients with T1D differs according to the type of additional AID. The presence of diabetes complications is lower in those with autoimmune thyroid disease while the presence of other AID is associated with higher rates of ischemic heart disease.

Filiaciones:
Gimenez-Perez, G:
 Hosp Gen Granollers, Dept Med, Endocrinol Sect, Granollers, Spain

 Univ Int Catalunya, Sch Med & Hlth Sci, Sant Cugat Del Valles, Spain

Vlacho, B:
 Fundacio Inst Univ Recerca Atencio Primaria Salut, Unitat Suport Recerca Barcelona, DAP Cat Grp, Barcelona, Spain

 Inst Recerca Hosp Santa Creu & St Pau IIBSantP, Barcelona, Spain

Navas, E:
 Fundacio Inst Univ Recerca Atencio Primaria Salut, Unitat Suport Recerca Barcelona, DAP Cat Grp, Barcelona, Spain

Mata-Cases, M:
 Fundacio Inst Univ Recerca Atencio Primaria Salut, Unitat Suport Recerca Barcelona, DAP Cat Grp, Barcelona, Spain

 Inst Salud Carlos III ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Barcelona, Spain

 Inst Catala Salut, Primary Hlth Care Ctr La Mina, Gerencia Atencio Primaria Barcelona Ciutat, St Adria De Besos, Spain

Real, J:
 Fundacio Inst Univ Recerca Atencio Primaria Salut, Unitat Suport Recerca Barcelona, DAP Cat Grp, Barcelona, Spain

 Inst Catala Salut, Primary Hlth Care Ctr La Mina, Gerencia Atencio Primaria Barcelona Ciutat, St Adria De Besos, Spain

Cos, X:
 Fundacio Inst Univ Recerca Atencio Primaria Salut, Unitat Suport Recerca Barcelona, DAP Cat Grp, Barcelona, Spain

 Inst Catala Salut, Primary & Hosp Innovat Dept, Innovat Off, Barcelona, Spain

Franch-Nadal, J:
 Fundacio Inst Univ Recerca Atencio Primaria Salut, Unitat Suport Recerca Barcelona, DAP Cat Grp, Barcelona, Spain

 Inst Salud Carlos III ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Barcelona, Spain

 Inst Catala Salut, Primary Hlth Care Ctr Raval Sud, Gerencia Atencio Primaria Barcelona Ciutat, Barcelona, Spain

Mauricio, D:
 Fundacio Inst Univ Recerca Atencio Primaria Salut, Unitat Suport Recerca Barcelona, DAP Cat Grp, Barcelona, Spain

 Inst Salud Carlos III ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Barcelona, Spain

 Hosp Santa Creu & Sant Pau, Dept Endocrinol & Nutr, Barcelona, Spain

 Univ Vic, Dept Med, Cent Univ Catalonia, Catalonia, Spain
ISSN: 01688227
Editorial
ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND, Países Bajos
Tipo de documento: Article
Volumen: 191 Número:
Páginas: 110031
WOS Id: 000858788300003
ID de PubMed: 35934173
imagen hybrid, All Open Access; Hybrid Gold

MÉTRICAS